Goldstraw P, Ball D, Jett JR, Le Chevalier T, et al. Non-small-cell lung cancer. Lancet 2011;378:1727-40.

Lam S, Boyle P, Healey GF, Maddison P, et al. EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer. Cancer Prev Res 2011;4:1126-34.

Leidinger P, Keller A, Borries A, Huwer H, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011;74:41-47.

Leidinger P, Keller A, Heisel S, Ludwig N, et al. Identification of Lung Cancer with High Sensitivity and Specificity by Blood Testing. Respir Res 2010;11:18.

Pecot CV, Li m, Zhang XJ, Rajanbabu R, et al. Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules. Cancer Epidemiol Biomarkers Prev 2012 doi:10.1158/1055-9965.EPI-11-0932.

Rahman SMJ, Gonzalez AL, Li M, Seeley EH, et al. Lung Cancer Diagnosis from Proteomic Analysis of Preinvasive Lesions. Cancer Res 2011;71:3009-17.

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409.

van’t Westeinde SC, van Klaveren RJ. Screening and Early Detection of Lung Cancer. Cancer J 2011;17:3-10.

Wood DE, Eapen GA, Ettinger DS, Hou L, et al. Lung Cancer Screening: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2012;10:240-265.